25
Participants
Start Date
September 12, 2022
Primary Completion Date
October 27, 2022
Study Completion Date
November 17, 2023
Electrographic Flow™ (EGF) mapping and ablation
"Electrographic Flow™ (EGF) mapping enables the full spatiotemporal reconstruction of organized atrial electrical wavefront propagation to identify active sources or origins of excitation that may trigger atrial fibrillation (AF).~EGF mapping involves 1 minute recordings of unipolar electrograms from a basket catheter, which are then processed with the EGF algorithm (Ablamap® Software). Several basket catheter positions are acquired in standard positions in both the left and right atria. EGF-identified sources with activity levels exceeding the recommended threshold are deemed significant and are targeted for ablation. The success of the ablation is confirmed through an EGF remap, where elimination of the source is defined as reduction of EGF source activity below the threshold."
Mount Sinai Hospital, New York
Piedmont Atlanta Hospital, Atlanta
Piedmont Healthcare, Athens
Erasmus MC, Rotterdam
Medicover Hospital, Warsaw
Lead Sponsor
Collaborators (1)
Cortex
INDUSTRY
Ablacon, Inc.
INDUSTRY